Impact of atopic dermatitis and loss-of-function mutations in the filaggrin gene on the development of occupational irritant contact dermatitis

British Journal of Dermatology

Volumn 168, Issue 2, 2013, Pages 326-332

  Visser, M J ^a   Landeck, L ^b   Campbell, L E ^c   McLean, W H I ^c   Weidinger, S ^d   Calkoen, F ^a   John, S M ^b   Kezic, Sanja ^a  

^a Amsterdam Public Health research institute   (Netherlands)

^b UNIVERSITY OF OSNABRÜCK   (Germany)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FILAGGRIN;

ADULT; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; FEMALE; GENOTYPE; GERMANY; HUMAN; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL ECZEMA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGE OF ONSET; DERMATITIS, ATOPIC; DERMATITIS, IRRITANT; DERMATITIS, OCCUPATIONAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MALE; MIDDLE AGED; MUTATION; RISK FACTORS;

EID: 84873197244     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12083     Document Type: Article

References (50)

1. Apfelbacher CJ, Funke U, Radulescu M, Diepgen TL,. Determinants of current hand eczema: results from case-control studies nested in the PACO follow-up study (PACO II). Contact Dermatitis 2010; 62: 363-70.
2. Berndt U, Hinnen U, Iliev D, Elsner P,. Is occupational irritant contact dermatitis predictable by cutaneous bioengineering methods? Results of the Swiss Metalworkers' Eczema Study (PROMETES) Dermatology 1999; 198: 351-4.
3. Flyvholm MA, Bach B, Rose M, Jepsen KF,. Self-reported hand eczema in a hospital population. Contact Dermatitis 2007; 57: 110-15.
4. John SM, Uter W, Schwanitz HJ,. Relevance of multiparametric skin bioengineering in a prospectively followed cohort of junior hairdressers. Contact Dermatitis 2000; 43: 161-8.
5. Schmid K, Broding HC, Uter W, Drexler H,. Transepidermal water loss and incidence of hand dermatitis in a prospectively followed cohort of apprentice nurses. Contact Dermatitis 2005; 52: 247-53.
6. Smit HA, van Rijssen A, Vandenbroucke JP, Coenraads PJ,. Susceptibility to and incidence of hand dermatitis in a cohort of apprentice hairdressers and nurses. Scand J Work Environ Health 1994; 20: 113-21.
7. Uter W, Pfahlberg A, Gefeller O, Schwanitz HJ,. Hand dermatitis in a prospectively followed cohort of hairdressing apprentices: final results of the POSH study. Prevention of occupational skin disease in hairdressers. Contact Dermatitis 1999; 41: 280-6.
8. Kezic S,. Genetic susceptibility to occupational contact dermatitis. Int J Immunopathol Pharmacol 2011; 24 (Suppl. 1): S73-8.
9. Diepgen TL, Coenraads PJ,. The epidemiology of occupational contact dermatitis. Int Arch Occup Environ Health 1999; 72: 496-506.
10. Coenraads PJ, Diepgen TL,. Risk for hand eczema in employees with past or present atopic dermatitis. Int Arch Occup Environ Health 1998; 71: 7-13.
11. Dickel H, Bruckner TM, Schmidt A, Diepgen TL,. Impact of atopic skin diathesis on occupational skin disease incidence in a working population. J Invest Dermatol 2003; 121: 37-40.
12. Bundesanstalt für Arbeitsschutz und Arbeitsmedizin. Technical Rules for Hazardous Substances 401: Risks Resulting From Skin Contact-Identification, Assessment, Measures (TRGS) 401. Available at: http://www.baua.de/en/Topics- from-A-to-Z/Hazardous-Substances/TRGS/TRGS-401-content.html (last accessed 11 October 2012).
13. Jungbauer FH, Piebenga WP, ten Berge EE, et al. Richtlijn contact eczeem-preventie, behandeling en begeleiding door de bedrijfsarts, Nederlandse Vereniging voor Arbeids en Bedrijfsgeneeskunde. [Guidelines for contact dermatitis-prevention, treatment and counselling by the occupational physician.] Utrecht: NVAB, 2007.
14. Jakasa I, de Jongh CM, Verberk MM, et al. Percutaneous penetration of sodium lauryl sulphate is increased in uninvolved skin of patients with atopic dermatitis compared with control subjects. Br J Dermatol 2006; 155: 104-9.
15. Jakasa I, Koster ES, Calkoen F, et al. Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss-of-function mutations. J Invest Dermatol 2011; 131: 540-2.
16. Brown SJ, McLean WH,. One remarkable molecule: filaggrin. J Invest Dermatol 2012; 132: 751-62.
17. Gruber R, Elias PM, Crumrine D, et al. Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function. Am J Pathol 2011; 178: 2252-63.
18. Novak N, Baurecht H, Schäfer T, et al. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol 2008; 128: 1430-5.
19. Scharschmidt TC, Man MQ, Hatano Y, et al. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol 2009; 124: 496-506. 506, e1-6.
20. Thyssen JP, Johansen JD, Linneberg A, et al. The association between null mutations in the filaggrin gene and contact sensitization to nickel and other chemicals in the general population. Br J Dermatol 2010; 162: 1278-85.
21. Barker JN, Palmer CN, Zhao Y, et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol 2007; 127: 564-7.
22. Brown SJ, Sandilands A, Zhao Y, et al. Prevalent and low-frequency null mutations in the filaggrin gene are associated with early-onset and persistent atopic eczema. J Invest Dermatol 2008; 128: 1591-4.
23. Greisenegger E, Novak N, Maintz L, et al. Analysis of four prevalent filaggrin mutations (R501X, 2282del4, R2447X and S3247X) in Austrian and German patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2010; 24: 607-10.
24. Lesiak A, Kuna P, Zakrzewski M, et al. Combined occurrence of filaggrin mutations and IL-10 or IL-13 polymorphisms predisposes to atopic dermatitis. Exp Dermatol 2011; 20: 491-5.
25. Marenholz I, Nickel R, Ruschendorf F, et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 2006; 118: 866-71.
26. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441-6.
27. Rogers AJ, Celedon JC, Lasky-Su JA, et al. Filaggrin mutations confer susceptibility to atopic dermatitis but not to asthma. J Allergy Clin Immunol 2007; 120: 1332-7.
28. Sandilands A, Terron-Kwiatkowski A, Hull PR, et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 2007; 39: 650-4.
29. Stemmler S, Parwez Q, Petrasch-Parwez E, et al. Two common loss-of-function mutations within the filaggrin gene predispose for early onset of atopic dermatitis. J Invest Dermatol 2007; 127: 722-4.
30. Weidinger S, Rodriguez E, Stahl C, et al. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J Invest Dermatol 2007; 127: 724-6.
31. O'Regan GM, Irvine AD,. The role of filaggrin in the atopic diathesis. Clin Exp Allergy 2010; 40: 965-72.
32. de Jongh CM, Khrenova L, Verberk MM, et al. Loss-of-function polymorphisms in the filaggrin gene are associated with an increased susceptibility to chronic irritant contact dermatitis: a case-control study. Br J Dermatol 2008; 159: 621-7.
33. Irvine AD, McLean WH, Leung DY,. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011; 365: 1315-27.
34. Skudlik C, Wulfhorst B, Gediga G, et al. Tertiary individual prevention of occupational skin diseases: a decade's experience with recalcitrant occupational dermatitis. Int Arch Occup Environ Health 2008; 81: 1059-64.
35. Skudlik C, Weisshaar E, Scheidt R, et al. Multicenter study 'Medical-Occupational Rehabilitation Procedure Skin-optimizing and quality assurance of inpatient-management (ROQ)'. J Dtsch Dermatol Ges 2009; 7: 122-6.
36. Lindberg M, Matura M,. Patch testing. In: Textbook of Contact Dermatitis (, Johansen JD, Frosch PJ, Lepoittevin JP, eds). Berlin: Springer, 2011; 439-64.
37. Rodriguez S, Gaunt TR, Day IN,. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 2009; 169: 505-14.
38. de Jongh CM, John SM, Bruynzeel DP, et al. Cytokine gene polymorphisms and susceptibility to chronic irritant contact dermatitis. Contact Dermatitis 2008; 58: 269-77.
39. Maziak W, Behrens T, Brasky TM, et al. Are asthma and allergies in children and adolescents increasing? Results from ISAAC phase I and phase III surveys in Münster, Germany Allergy 2003; 58: 572-9.
40. Peters AS, Kellberger J, Vogelberg C, et al. Prediction of the incidence, recurrence, and persistence of atopic dermatitis in adolescence: a prospective cohort study. J Allergy Clin Immunol 2010; 126: 590-5.
41. Ingordo V, D'Andria G, D'Andria C,. Adult-onset atopic dermatitis in a patch test population. Dermatology 2003; 206: 197-203.
42. Ozkaya E,. Adult-onset atopic dermatitis. J Am Acad Dermatol 2005; 52: 579-82.
43. Molin S, Vollmer S, Weiss EH, et al. Filaggrin mutations may confer susceptibility to chronic hand eczema characterized by combined allergic and irritant contact dermatitis. Br J Dermatol 2009; 161: 801-7.
44. Thyssen JP, Carlsen BC, Menné T, et al. Filaggrin null mutations increase the risk and persistence of hand eczema in subjects with atopic dermatitis: results from a general population study. Br J Dermatol 2010; 163: 115-20.
45. Kawasaki H, Nagao K, Kubo A, et al. Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice. J Allergy Clin Immunol 2012; 129: 1538-46.
46. Flohr C, England K, Radulovic S, et al. Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age. Br J Dermatol 2010; 163: 1333-6.
47. Kezic S, O'Regan GM, Lutter R, et al. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency. J Allergy Clin Immunol 2012; 129: 1031-9.
48. Kezic S, O'Regan GM, Yau N, et al. Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity. Allergy 2011; 66: 934-40.
49. Brown SJ, Kroboth K, Sandilands A, et al. Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect. J Invest Dermatol 2012; 132: 98-104.
50. Howell MD, Kim BE, Gao P, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007; 120: 150-5.